There’s something undeniably special about going big for the people who mean the most to you. While thoughtful, budget-friendly gifts have their place, every once in a while, splurging on something ...
Russell Crowe recently spoke to Australia’s Triple J and shared his disappointment with “Gladiator 2,” Ridley Scott’s 2024 sequel to the Oscar-winning “Gladiator.” Crowe headlined the original movie ...
In 2021, Sharlto Copley (“District 9,” “The Witcher”) and Aiysha Hart (“Mogul Mowgli,” “Colette”) spent five months in a scenic desert area near the site of the futuristic city of NEOM to shoot Saudi ...
Diego Pavia has once again taken the college football world by storm, and so has his family. In the midst of directing No. 13 Vanderbilt onto the College Football Playoff bubble, his brother was ...
The Omaha Police Department reports it has seized 1,194 guns since the start of 2025. The reporting shows a little less than half of those have been connected to crimes. Sign up for our Newsletters ...
KETV INVESTIGATES THE IMPACT OF STOLEN GUNS. THE OMAHA POLICE DEPARTMENT HAS SEIZED 1194 GUNS SINCE THE START OF THE YEAR. REPORTING SHOWS A LITTLE LESS THAN HALF OF THOSE HAVE BEEN CONNECTED TO ...
If the outbreaks cannot be extinguished soon, the United States will lose its “elimination status,” as determined by the World Health Organization. By Apoorva Mandavilli and Teddy Rosenbluth The ...
Since Elon Musk decided Twitter was now to be known as X, things have gone from bad to worse. I still maintain nobody calls it X. The latest update that X is rolling out on what was the once great ...
Apple, Amazon, Lockheed Martin, Microsoft, Google, Coinbase, Comcast and Meta are just some of the major companies who have made donations to build President Donald Trump’s proposed 90,000-square-foot ...
Unity Software is rated a buy, positioned at an inflection point for double-digit growth, driven by its CS and GS segments and the Vector launch. U's new Vector AI ad platform is a game-changer, ...
Bristol Myers Squibb has ended its R&D losing streak with a hit on one of the dual primary endpoints in a phase 3 multiple myeloma trial. But with the study continuing to evaluate the other primary ...